For example, in breast cancer, abnormal upregulation of the luminal-lineage TF FOXA1 modifies genome-wide enhancer activity and induces transcriptional reprogramming to establish an endocrine-resistant state in metastatic tumors (11). Here, FOXA1 is linked to breast cancer.